Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
15 Results for "
protease-activated receptor-4
" in MedChemExpress (MCE) Product Catalog:
Products (15)
15 Results for "protease-activated receptor-4" in MCE Product Catalog:
Cat. No.: HY-P0297
CAS No.: 245443-52-1
Research Areas:
1
1 Cited Publications
Cat. No.: HY-19837
CAS No.: 1478712-37-6
Research Areas:
BMS-986120 is a first-in-class oral and reversible protease-activated receptor 4 (PAR4) antagonist, with IC50s of 9.5 nM and 2.1 nM in human and monkey blood, respectively. BMS-986120 has potent and selective antiplatelet effects .
Research Areas:
BMS-98614 is an orally active, selective thrombin receptor protease-activated receptor-4 (PAR-4) antagonist with an IC50 value of 0.4 nM. BMS-98614 has excellent antithrombotic effect .
Cat. No.: HY-P4004
CAS No.: 245443-51-0
Research Areas:
Cat. No.: HY-P5875A
Research Areas:
Cat. No.: HY-128345
CAS No.: 1477497-01-0
Research Areas:
UDM-001651 is a potent, selective, and orally bioavailable protease-activated receptor 4 (PAR4) antagonist (IC50=4 nM; Kd=1.4 nM). UDM-001651 shows antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay (γ-Thr PRP) .
Cat. No.: HY-162409
CAS No.: 3057206-41-1
Research Areas:
PAR4 antagonist 4 (Compound 37) is a selective antagonist for protease activated receptor 4 (PAR4). PAR4 antagonist 3 exhibits antiplatelet efficacy with IC50 of 14.2 nM. PAR4 antagonist 3 improves metabolic stablility in human liver microsomes with T1/2 of 42.5 min .
Cat. No.: HY-163341
CAS No.: 2173201-65-3
Research Areas:
PAR4 antagonist 1 (Compound 48) is a protease activated receptor 4 (PAR4) antagonist with an IC50 of 1.8 nM. PAR4 antagonist 1 has an IC50 of 2 nM against γ-thrombin-activated PAR4 in platelet-rich plasma (PRP). PAR4 antagonist 1 can be used in antithrombotic research .
Cat. No.: HY-P1313
CAS No.: 225779-44-2
Synonyms: GYPGQV
Research Areas:
Cat. No.: HY-P1313A
Synonyms: GYPGQV TFA
Research Areas:
Cat. No.: HY-P10577
Research Areas:
Cat. No.: HY-P5875
CAS No.: 1021346-05-3
Research Areas:
Cat. No.: HY-161401
Research Areas:
PAR4 antagonist 2 (Compound 31) is a protease activated receptor 4 (PAR4) antagonist, with IC50 values of 95 nM and 367 nM for human PAR4 and mouse PAR4. PAR4 antagonist 2 is active against PAR4 activation by the native protease thrombin cleavage but not the synthetic PAR4 agonist peptide AYPGKF .
Cat. No.: HY-162408
CAS No.: 3057206-40-0
Research Areas:
PAR4 antagonist 3 (Compound 36) is a selective antagonist for protease activated receptor 4 (PAR4). PAR4 antagonist 3 exhibits antiplatelet efficacy with IC50 of 26.1 nM. PAR4 antagonist 3 improves metabolic stablility in human liver microsomes with T1/2 of 97.6 min .
Cat. No.: HY-183983
CAS No.: 2173066-25-4
Research Areas:
PAR4 antagonist 9 is an orally active protease-activated receptor 4 (PAR4) antagonist with an IC50 of 2 nM against human targets. PAR4 antagonist 9 functionally modulates PAR4 and inhibits platelet aggregation. PAR4 antagonist 9 can be used in studies related to arterial thrombosis .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
